ArticleScientific reports2025
The predictive value of the vasoactive inotropic score in the postoperative treatment of patients suffering from infective endocarditis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Vaso-active inotropic scores: Clinical value, pros and cons.JHLT open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study aimed to analyze the predictive value of the vasoactive inotropic score (VIS) in the postoperative treatment of patients undergoing valve surgery for infective endocarditis (IE). At our institution, 334 patients underwent valve surgery for IE from 01/2016 to 12/2022. Patients with postoperative MCS device were excluded from this study. Data are presented as medians and 25th - 75th percentiles, or absolute numbers and percentages. Non-survivors had a significantly higher EuroSCORE II preoperatively (4.5 (2.3-9.8)% vs. 12.6 (5.7-20.9)%, p < 0.001). In non-survivors, Staphylococcus (89 (32.1%) vs. 20 (54.1%), p = 0.01) and Staphylococcus aureus (62 (22.4%) vs. 14(37.8%), p = 0.064) were significantly more frequently identified as causative pathogens. Non-survivors had significantly higher IL-6 levels at POD 1, 2 and 4 compared to survivors (p < 0.021). Non survivor had significantly higher VIS immediately postoperatively as well as 6 h, 12 h, 24 h, 36 h and 48 h after surgery. In addition, VIS at 48 h was identified as an independent variable associated with non-survival at values > 4.1. When comparing the ROC of lactate, ScvO2 and VIS after 48 h, VIS showed the highest AUC. The VIS is particularly suitable for patients with infective endocarditis due to combined assessment of postoperative cardiovascular dysfunction and IE related inflammatory response. We provided suggestive evidence that the amount of cardiovascular support represented as the VIS has a predictive value regarding mortality in patients undergoing valve replacement for IE. In addition, VIS showed superiority compared to conventional scoring systems for predicting outcome in the intensive care of postoperative IE patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.